Skip to main content
menu sluit menu
Home Home
Login
Main navigation
  • Library
  • Calendar
  • e-Learning
  • News
    • Veterinary News In this section you find veterinary news
    • Recent Additions All content that was recently added to the IVIS library
  • Get involved
    • Donate Support IVIS, make a donation today
    • Media kit Promote your e-learning & events on IVIS
    • Add your e-learning & events to the IVIS calendar
    • Publish on IVIS Publish your work with us
  • About
    • Mission Our Mission Statement
    • What we do More info about IVIS and what we do
    • Who we are More info about the IVIS team
    • Authors See list of all IVIS authors and editors
  • Contact
User tools menu
User tools menu
Main navigation
  • Library
  • Calendar
  • e-Learning
  • News
    • Veterinary News In this section you find veterinary news
    • Recent Additions All content that was recently added to the IVIS library
  • Get involved
    • Donate Support IVIS, make a donation today
    • Media kit Promote your e-learning & events on IVIS
    • Add your e-learning & events to the IVIS calendar
    • Publish on IVIS Publish your work with us
  • About
    • Mission Our Mission Statement
    • What we do More info about IVIS and what we do
    • Who we are More info about the IVIS team
    • Authors See list of all IVIS authors and editors
  • Contact
Follow IVIS
  • Twitter
  • Facebook
Support IVIS

Breadcrumb

  1. Home
  2. Library
  3. Veterinary Evidence
  4. Veterinary Evidence - Vol 7 N°3, Jul-Sep 2022
  5. Does trazodone reduce anaesthetic agent requirement in dogs?
Veterinary Evidence  cover vol 7 no 3
Back to Table of Contents
Add to My Library
Close
Would you like to add this to your library?

Get access to all handy features included in the IVIS website

  • Get unlimited access to books, proceedings and journals.
  • Get access to a global catalogue of meetings, on-site and online courses, webinars and educational videos.
  • Bookmark your favorite articles in My Library for future reading.
  • Save future meetings and courses in My Calendar and My e-Learning.
  • Ask authors questions and read what others have to say.
Sign in Register
Comments
Share:
  • Facebook
  • LinkedIn
  • Mail
  • Twitter

Does trazodone reduce anaesthetic agent requirement in dogs?

Author(s):

Gemma Stewart

In: Veterinary Evidence - Vol 7 N°3, Jul-Sep 2022 by Veterinary Evidence
Updated:
AUG 09, 2022
Languages:
  • EN
Back to Table of Contents
Add to My Library
Close
Would you like to add this to your library?

Get access to all handy features included in the IVIS website

  • Get unlimited access to books, proceedings and journals.
  • Get access to a global catalogue of meetings, on-site and online courses, webinars and educational videos.
  • Bookmark your favorite articles in My Library for future reading.
  • Save future meetings and courses in My Calendar and My e-Learning.
  • Ask authors questions and read what others have to say.
Sign in Register
SHARE:
  • Facebook
  • LinkedIn
  • Mail
  • Twitter
    Read

    PICO question

    In dogs undergoing anaesthesia, does the use of oral trazodone given 2 hours before induction of anaesthesia reduce injectable or inhalant anaesthetic agent requirements?

    Clinical bottom line

    Category of research question

    Treatment

    The number and type of study designs reviewed

    Two randomised controlled trials were critically appraised

    Strength of evidence

    Moderate

    Outcomes reported

    Trazodone was shown to have a significant isoflurane minimum alveolar concentration (MAC) sparing effect for isoflurane. There is also evidence to suggest trazodone has a similar effect on the cardiovascular system as acepromazine

    Conclusion

    Trazodone should be considered as part of a multimodal approach to anaesthesia in dogs to reduce the injectable and inhalant anaesthetic agent requirements

    How to apply this evidence in practice

    The application of evidence into practice should take into account multiple factors, not limited to: individual clinical expertise, patient’s circumstances and owners’ values, country, location or clinic where you work, the individual case in front of you, the availability of therapies and resources.

    Knowledge Summaries are a resource to help reinforce or inform decision making. They do not override the responsibility or judgement of the practitioner to do what is best for the animal in their care.

    [...]

    Appraisal, application and reflection

    The randomised controlled trials appraised are designed appropriately to address the PICO question (EBVM Network, 2021). Hoffman et al. (2018) used no treatment as a comparator and Murphy et al. (2017) used a recognised premedication acepromazine as a comparator. The level of evidence appraised is level two based on the Oxford Centre for Evidence-based Medicine Levels of Evidence (CEBM, 2009) which provides fairly robust evidence towards answering the PICO question. There is no higher level of evidence published that was suitable to answer the PICO question. Both studies are based on objective assessments. Randomly allocating the treatment group reduces potential bias from allocation and with the observer.

    The evidence appraised demonstrates trazodone provides an isoflurane minimum alveolar concentration (MAC) sparing effect in anaesthetised dogs (Hoffman et al., 2018) and has similar cardiovascular effects to acepromazine in anaesthetised, healthy dogs (Murphy et al., 2017). Hoffman et al. (2018) provides supporting evidence that trazodone does reduce the MAC of isoflurane reported as 1.02 ± 0.11% reducing to 0.85 ± 0.17% with the addition of trazodone to the protocol (p = 0.01, 95% confidence interval -0.25–-0.05). Murphy et al. (2017) could find no significant differences between trazodone and acepromazine, a strong comparator which has been shown independently to have a MAC sparing effect (Monteiro et al., 2016). However, there were multiple confounding factors which may have influenced the results. Primarily, this study reported on the reduction in propofol dose required for induction of anaesthesia. No difference was found between the acepromazine and trazodone groups of patients. Acepromazine has been shown to reduce the propofol dose required for the induction of anaesthesia (Dantino et al., 2021), therefore trazodone may have a similar effect, although difficult to determine due to confounding factors of varied acepromazine doses and rate of propofol administration. Acepromazine is known to have a reducing effect on blood pressure in dogs (Grasso et al., 2015), therefore by having no significant difference in cardiovascular variables, trazodone may also have an impact on blood pressure. Results demonstrated by Hoffman et al. (2018) show that blood pressure and heart rate were similar in cases that had received trazodone or higher levels of isoflurane, which would suggest trazodone could have cardiovascular effects.

    Both papers accounted for all of the animals included in the trial in the conclusion. Hoffman et al. (2018) report results from all of the animals included in the trial. Murphy et al. (2017) state some of the participants in their trial were excluded from the results, mostly because a standardised protocol was not used throughout the procedure, for example the use of isoflurane (n = 28) versus sevoflurane (n = 2). Hoffman et al. (2018) used a crossover design to the study, enabling a direct comparison between interventions in all participants. Other than the intervention and the comparator, the groups were treated equally in both studies appraised.

    There are limitations to the research available. Inclusion and exclusion factors are well defined in both papers, but participants are not fully representative of all patients undergoing the multitude of procedures performed in practice. Whilst they are of the correct species, the evidence focuses solely on systemically healthy dogs. Potential candidates with concurrent disease were excluded from both studies, limiting the application of the research in clinical practice where many of the patients suffer with concurrent disease, highlighting an area for further research. There are weaknesses in the Murphy et al. (2017) study design, despite being a randomised control trial, that limit the conclusions drawn from the research. No control was used for comparison meaning it cannot be determined whether or not trazodone reduced the quantity of propofol required for the induction of anaesthesia. The comparator, acepromazine, had a 200% variation in dose at the discretion of the anaesthetist, affecting the validity of the results obtained by comparison.

    Further research would be desirable to improve the external validity of the evidence presented. The multiple variables that could be influencing the results in the Murphy et al. (2017) study’s conclusion that there are no significant differences between acepromazine and trazodone are concerning and affect the level of reliability of the results. Hoffman et al. (2018) do provide reliable results although on a small scale with a narrower population demographic.

    All of the evidence appraised is based on a single dose of orally administered trazodone 2 hours before the induction of anaesthesia, administered in the clinical setting. As an anxiolytic drug, if administered ahead of the stressor that is travelling and visiting a veterinary practice the effects may be improved and provide a more practical approach to the administration of trazodone as part of a pre-anaesthetic protocol. Hoffman et al. (2018) used an 8 mg/kg dose 2 hours before the induction of anaesthesia and Murphy et al. (2017) used a 5–7 mg/kg dose depending on body weight. The BSAVA formulary stated dose for use in dogs to treat chronic anxiety is ‘5–10 kg, 25 mg p.o. q24h; 11–20 kg, 50 mg p.o. q24h; >21 kg, 100 mg p.o. q24h’ (Ramsey, 2017). Jay et al. (2013) report the time to maximum plasma concentration following oral administration as 445 minutes ± 271 minutes which would mean the 2 hours allowed prior to induction would be inadequate. This could also be problematic when considering adding trazodone as part of premedication as to reach maximum plasma concentration, it would need to be administered 7.5 hours before induction.

    Beneficial effects of the treatment were identified and no significant adverse effects were noted with the administration of trazodone when compared with no intervention or acepromazine. Murphy et al. (2017) reported one dog experienced priaprism 24 hours post administration of trazodone which was resolved with treatment, this is a rare side effect also noted in humans (Abber et al., 1987). Trazodone has been shown to reduce stress in postoperative patients (Gruen et al., 2014). This could be extrapolated to patients confined ahead of anaesthesia, who may therefore require less anaesthetic agents to induce and maintain a suitable depth of anaesthesia. There could be an argument for combining it as part of a multimodal approach to the pre-anaesthetic protocol, however, the reported MAC reduction of trazodone is less than other agents such as alpha-2-agonists (Sinclair, 2003) or opioids (Credie et al., 2010).

    In conclusion, there is some strong evidence to support the intervention of trazodone to reduce the dose of inhalant anaesthetic agent administered. Consideration must be taken regarding the use of the cascade due to lack of licensing and the potential for only a modest reduction in MAC. Administration orally 2 hours before the induction of anaesthesia, may be an inadequate time to reach maximum effect. Further research would be beneficial to establish a stronger argument for the inclusion of trazodone in a multimodal anaesthetic protocol.

    […]

    View full text
    Back to Table of Contents
    Add to My Library
    Close
    Would you like to add this to your library?

    Get access to all handy features included in the IVIS website

    • Get unlimited access to books, proceedings and journals.
    • Get access to a global catalogue of meetings, on-site and online courses, webinars and educational videos.
    • Bookmark your favorite articles in My Library for future reading.
    • Save future meetings and courses in My Calendar and My e-Learning.
    • Ask authors questions and read what others have to say.
    Sign in Register
    Comments (0)

    Ask the author

    0 comments
    Submit
    Close
    Would to like to further discuss this item?

    Get access to all handy features included in the IVIS website

    • Get unlimited access to books, proceedings and journals.
    • Get access to a global catalogue of meetings, on-site and online courses, webinars and educational videos.
    • Bookmark your favorite articles in My Library for future reading.
    • Save future meetings and courses in My Calendar and My e-Learning.
    • Ask authors questions and read what others have to say.
    Sign in Register
    About

    Copyright Statement

    © All text and images in this publication are copyright protected and cannot be reproduced or copied in any way.
    Related Content

    Readers also viewed these publications

    • Journal Issue

      Veterinary Evidence - Vol 8 N°1, Jan-Mar 2023

      In: Veterinary Evidence
      MAR 19, 2023
    • Proceeding

      LAVC - Annual Conference - Lima, 2022

      By: Latin American Veterinary Conference
      MAR 18, 2023
    • Journal Issue

      Cirugía de urgencias - Argos N°246, Marzo 2023

      In: Argos
      MAR 10, 2023
    • Proceeding

      AVEF - Conférence Annuelle - Reims, 2022

      By: Association des Vétérinaires Équins Français
      MAR 03, 2023
    • Proceeding

      LAVC - Annual Conference - Lima, 2021

      By: Latin American Veterinary Conference
      FEB 19, 2023
    • Journal Issue

      Veterinary Evidence - Vol 7 N°4, Oct-Dec 2022

      In: Veterinary Evidence
      FEB 05, 2023
    • Journal Issue

      Patología cardiaca - Argos N°245, Enero/Febrero 2023

      In: Argos
      JAN 30, 2023
    • Proceeding

      SFT - Theriogenology Annual Conference - Bellevue, 2022

      By: Society for Theriogenology
      JAN 10, 2023
    • Journal Issue

      Urgencias y cuidados intensivos - Argos N°244, Diciembre 2022

      In: Argos
      DEC 31, 2022
    • Journal Issue

      Israel Journal of Veterinary Medicine - Vol. 77(4), Dec. 2022

      In: Israel Journal of Veterinary Medicine
      DEC 31, 2022
    • Proceeding

      ISCFR-EVSSAR Symposium - Italy 2022

      By: International Symposium on Canine and Feline Reproduction
      DEC 02, 2022
    • Journal Issue

      Patología endocrina - Argos N°243, Noviembre 2022

      In: Argos
      NOV 27, 2022
    • Proceeding

      ACVIM & ECEIM - Consensus Statements

      By: American College of Veterinary Internal Medicine
      NOV 11, 2022
    • Journal Issue

      Traumatología y neurología - Argos Nº242, Octubre 2022

      In: Argos
      NOV 10, 2022
    • Chapter

      Tibia and Tarsus

      In: Current Techniques in Small Animal Surgery (5th Edition)
      NOV 07, 2022
    • Chapter

      Femur and Stifle Joint

      In: Current Techniques in Small Animal Surgery (5th Edition)
      OCT 28, 2022
    • Journal Issue

      Medicina felina - Argos Nº241, Septiembre 2022

      In: Argos
      OCT 24, 2022
    • Chapter

      Sacroiliac Joint, Pelvis, and Hip Joint

      In: Current Techniques in Small Animal Surgery (5th Edition)
      OCT 17, 2022
    • Journal Issue

      Veterinary Evidence - Vol 7 N°2, Apr-Jun 2022

      In: Veterinary Evidence
      OCT 07, 2022
    • Journal Issue

      Veterinary Evidence - Vol 7 N°3, Jul-Sep 2022

      In: Veterinary Evidence
      OCT 04, 2022
    • Chapter

      Amputation of the Forelimb

      In: Current Techniques in Small Animal Surgery (5th Edition)
      OCT 02, 2022
    • Journal Issue

      Israel Journal of Veterinary Medicine - Vol. 77(3), Sep. 2022

      In: Israel Journal of Veterinary Medicine
      SEP 30, 2022
    • Chapter

      Carpus, Metacarpus, and Phalanges

      In: Current Techniques in Small Animal Surgery (5th Edition)
      SEP 26, 2022
    • Chapter

      Radius and Ulna

      In: Current Techniques in Small Animal Surgery (5th Edition)
      SEP 16, 2022
    • Chapter

      Humerus and Elbow Joint

      In: Current Techniques in Small Animal Surgery (5th Edition)
      SEP 10, 2022
    • Load more
    Subscribe

    Veterinary Evidence is an online, open access, peer-reviewed journal owned and published by RCVS Knowledge.  If you would like to receive updates on recent publications, you can register here.  If you would like to submit an manuscript for publication in the Veterinary Evidence journal, you can consult the Guidelines for Authors.

     

    Subscribe today
    Back To Top
    Become a member of IVIS and get access to all our resources
    Create an account
    Sign in
    Leading the way in providing veterinary information
    About IVIS
    • Mission
    • What we do
    • Who we are
    Need help?
    • Contact
    Follow IVIS
    • Twitter
    • Facebook
    International Veterinary Information Service (IVIS) is a not-for-profit organization established to provide information to veterinarians, veterinary students, technicians and animal health professionals worldwide using Internet technology.
    Support IVIS
    © 2023 International Veterinary Information Service
    • Disclaimer
    • Privacy Policy